Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Intensity modulated proton therapy for early-stage glottic cancer: high-precision approach to laryngeal function preservation with exceptional treatment tolerability.

12/01/2023
/ Publications

This study reported outcomes of 15 patients with T1-2N0 glottic cancer treated to a total dose 70 Gy. The one- and two-year OS and metastases-free survival were...

A Prospective Study of Mucosal Sparing Radiation Therapy in Resected Oropharyngeal Cancer Patients.

16/01/2023
/ Publications

This study reported results of 61 patients with HPV-positive oropharyngeal cancer treated with mucosal sparing radiation therapy. 44 (72%) patients were treated...

Head & Neck Cancer

24/02/2023
/ Webinar

Steven Frank talks about the rationale behind using proton therapy for head & neck cancers. He also presents the results of MDACC's initial experience with...

DynamicARC: the Future of Proton Therapy

24/02/2023
/ Webinar
/
ARC therapy

DynamicARC® proton therapy is one of the most promising developments in proton radiation therapy, as it allows dynamic irradiation while the gantry is rotating...

Hypofractionation in Proton Therapy: radiobiological bases and clinical applications

19/04/2023
/ Webinar
/
Hypofractionation

The use of hypofractionated schedules in proton therapy is rapidly increasing. Their application has several advantages, including the reduction of overall...

Model-based for nasopharyngeal carcinoma

24/09/2020
/ Webinar
/
Model-based approach
VMAT
ARC therapy
IMRT
IMPT

Proton therapy and oral mucositis in oral & oropharyngeal cancers: outcomes, dosimetric and NTCP benefit.

05/09/2023
/ Publications

This is a study by the Apollo group Chennai, India. 22 patients with oral cavity and oropharyngeal cancers treated with IMPT were reviewed. The average mean...

Proton beam therapy in multimodal treatment for locally advanced squamous cell carcinoma of the nasal cavity and paranasal sinus.

05/09/2023
/ Publications

This study from Japan reported clinical outcomes of patients with locally advanced nasal cavity and paranasal sinus (NPSCC) treated with postoperative PBT or...

Phase II Trial of Combined Durvalumab Plus Tremelimumab with Proton Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.

23/11/2023
/ Publications

This study reported outcomes of 31 recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) patients treated with combined proton therapy and...

Risk of temporal lobe necrosis between proton beam and volumetric modulated arc therapies in patients with different head and neck cancers.

23/11/2023
/ Publications

This study reviewed 483 patients with various types of head and neck cancer (HNC), and reported that the nasopharyngeal carcinoma (NPC) patients had a higher...